4//SEC Filing
HSIA DAVID C 4
Accession 0001179110-03-011522
CIK 0000884629other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 3:20 PM ET
Size
6.1 KB
Accession
0001179110-03-011522
Insider Transaction Report
Form 4
HSIA DAVID C
Sr. VP, Scientific Affairs
Transactions
- Sale
Common Stock, par value $0.0033
2003-11-28$47.12/sh−1,250$58,897→ 595,314 total(indirect: By Trust)
Holdings
- 60,000
Common Stock, par value $0.0033
- 40,000(indirect: By Trust)
Common Stock, par value $0.0033
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 plans dated August 27, 2003.
Documents
Issuer
WATSON PHARMACEUTICALS INC
CIK 0000884629
Entity typeother
Related Parties
1- filerCIK 0001258176
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 3:20 PM ET
- Size
- 6.1 KB